This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Government of the United States, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 22 
1 out of 3,693 
Years Active: 2009-2011
Title: Jim A Turpin: Innovator in Anti-Retroviral Research
Introduction
Jim A Turpin is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of anti-retroviral research, holding 2 patents that focus on innovative compounds for treating retroviral infections such as HIV.
Latest Patents
Turpin's latest patents include "Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents." These patents describe certain thiol and acylthiol compounds that inhibit retrovirus growth by targeting the highly conserved zinc finger regions of essential viral proteins. The compounds and compositions outlined in these patents are not only useful for treating retroviral infections but also for preparing vaccines comprised of inactivated retroviruses like HIV. Additionally, they play a role in preventing the transmission of such retroviruses and in detecting retroviral proteins.
Career Highlights
Throughout his career, Jim A Turpin has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His work has contributed to advancements in medical research and public health.
Collaborations
Turpin has collaborated with notable colleagues such as John K Inman and Atul Goel, further enhancing the impact of his research in the scientific community.
Conclusion
Jim A Turpin's innovative work in the field of anti-retroviral agents showcases his dedication to improving health outcomes for individuals affected by HIV. His contributions continue to influence research and development in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile